AURAAura Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of Aura Biosciences, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AURAThis | $632M#3 | — | 2.0x#3 | — | — | -22.2%#5 | — | -33.7%#2 | — | — | — | — |
| SANA | $757M#1 | — | 4.9x#5 | — | — | 8.5%#3 | — | -158.0%#5 | — | — | — | — |
| DNA | $672M#2 | — | 1.6x#1 | 3.9x#1 | -25.1%#3 | 42.8%#1 | -185.3%#1 | -0.1%#1 | — | — | -12.3%#2 | — |
| CCCC | $411M#5 | — | 1.7x#2 | 11.4x#3 | 1.0%#2 | 0.3%#4 | -320.5%#2 | -42.5%#3 | — | — | 28.2%#1 | — |
| EDIT | $419M#4 | — | 4.0x#4 | 10.3x#2 | 25.4%#1 | 32.5%#2 | -394.9%#3 | -152.0%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice